Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Godwin

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Microbiology|April 15, 2026
Genome-guided discovery and computational prioritization of next generation drug development from <i>Streptomyces</i> sp. VITGV156 (MCC 4965)Veilumuthu Pattapulavar, Manisha Shah, Praisy Joy Bell I, et al.
Leukemia & Lymphoma|November 21, 2008
Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trialSucha Nand, John Godwin, Scott Smith, et al.
Blood|January 2, 2007
Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trialsNataliya Kuptsova, Kenneth J Kopecky, John Godwin, et al.
Journal of Environmental Health Science & Engineering|June 18, 2024
Nanosorbent based on coprecipitation of ZnO in goethite for competitive sorption of Cd(II)-Pb(II) and Cd(II)-Pb(II)-Ni(II) systemsJohn Godwin, Jacques Romain Njimou, Nasalam Abdus-Salam, et al.
Frontiers in Microbiology|June 1, 2026
Genome mining strategies to unlock the metabolic potential of <i>Streptomyces</i> sp. VITGV100 (MCC 4961) for next-generation antimicrobial discoveryVeilumuthu Pattapulavar, Saranyadevi Subburaj, Sathiyabama Ramanujam, et al.
Leukemia & Lymphoma|May 21, 2021
Postinfusion monitoring costs by site of care for patients with relapsed/refractory large B-cell lymphoma receiving third- or later-line treatment with lisocabtagene maraleucel in the TRANSCEND NHL 001 and OUTREACH trialsM Lia Palomba, Monika Parisi Jun, James Lymp, et al.
Integrative and Comparative Biology|August 16, 2013
Masculinizing effect of background color and cortisol in a flatfish with environmental sex-determinationJamie L Mankiewicz, John Godwin, Brittany L Holler, et al.
Frontiers in Bioinformatics|April 10, 2025
<i>Streptomyces</i> sp. VITGV156 secondary metabolite binds pathogenic protein PBP2a and Beta-lactamaseVeilumuthu Pattapulavar, Sathiyabama Ramanujam, Manisha Shah, et al.
Blood|April 29, 2009
Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndromeAzra Raza, Naomi Galili, Scott Smith, et al.
Blood|August 5, 2004
Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell linesChristiane Houde, Yulin Li, Lynda Song, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Microbiology|April 15, 2026
Genome-guided discovery and computational prioritization of next generation drug development from <i>Streptomyces</i> sp. VITGV156 (MCC 4965)Veilumuthu Pattapulavar, Manisha Shah, Praisy Joy Bell I, et al.
Leukemia & Lymphoma|November 21, 2008
Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trialSucha Nand, John Godwin, Scott Smith, et al.
Blood|January 2, 2007
Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trialsNataliya Kuptsova, Kenneth J Kopecky, John Godwin, et al.
Journal of Environmental Health Science & Engineering|June 18, 2024
Nanosorbent based on coprecipitation of ZnO in goethite for competitive sorption of Cd(II)-Pb(II) and Cd(II)-Pb(II)-Ni(II) systemsJohn Godwin, Jacques Romain Njimou, Nasalam Abdus-Salam, et al.
Frontiers in Microbiology|June 1, 2026
Genome mining strategies to unlock the metabolic potential of <i>Streptomyces</i> sp. VITGV100 (MCC 4961) for next-generation antimicrobial discoveryVeilumuthu Pattapulavar, Saranyadevi Subburaj, Sathiyabama Ramanujam, et al.
Leukemia & Lymphoma|May 21, 2021
Postinfusion monitoring costs by site of care for patients with relapsed/refractory large B-cell lymphoma receiving third- or later-line treatment with lisocabtagene maraleucel in the TRANSCEND NHL 001 and OUTREACH trialsM Lia Palomba, Monika Parisi Jun, James Lymp, et al.
Integrative and Comparative Biology|August 16, 2013
Masculinizing effect of background color and cortisol in a flatfish with environmental sex-determinationJamie L Mankiewicz, John Godwin, Brittany L Holler, et al.
Frontiers in Bioinformatics|April 10, 2025
<i>Streptomyces</i> sp. VITGV156 secondary metabolite binds pathogenic protein PBP2a and Beta-lactamaseVeilumuthu Pattapulavar, Sathiyabama Ramanujam, Manisha Shah, et al.
Blood|April 29, 2009
Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndromeAzra Raza, Naomi Galili, Scott Smith, et al.
Blood|August 5, 2004
Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell linesChristiane Houde, Yulin Li, Lynda Song, et al.
Pageof 7